National Psoriasis Foundation Issues RFP for Psoriasis Prevention Initiative

The National Psoriasis Foundation has long recognized the importance of research to improve the lives of those living with psoriatic disease.

To that end, and inspired by the NIH Accelerating Medicines Partnership (AMP), NPF will invest an estimated $6.5 million over the next five years to establish the Psoriasis Prevention Initiative (PPI), a multi-institution, multi-disciplinary, team-based research network whose stated aim is to identify an intervention that will prevent the onset of psoriatic disease, disease relapse, or relevant comorbidities.

To that end, NPF has issued an RFP for th3 initiative. Priority will be given to proposals that show promise to establish or develop innovative collaborations among basic, translational, and clinical researchers; identify a multi-faceted, multi-disciplinary, multi-institutional collaborative  research approach; and have the highest likelihood of developing an intervention that will prevent the onset of psoriatic disease, prevent the onset of psoriatic disease relapse, or prevent the onset of related comorbidities.

NPF will fund proposals that have the potential to achieve significant progress toward this aspirational goal within five years, with funding to occur in three phases. Under the RFP, one to two grants of up to $250,000 a year will be awarded; upon demonstration of progress and promising future potential, one grantee will be awarded year-two funding of up to $1.5 million; and upon continued demonstration of progress the grantee will have the opportunity to renew their proposal for up $1.5 million annually for an additional three years of funding.

Applicants must include co-principal investigators from a minimum of two institutions and three different disciplines; there is no limit to the number of co-principal investigators proposed for the project. PIs must be eligible to apply for research grants under the guidelines of his/her host institution or organization, although they need not be a U.S. citizen and the research need not take place in the United States.

Letters of Intent are due December 12. Upon review, selected applicants will be invited to submit an application by April 1, 2020.

See the National Psoriasis Foundation website for complete program guidelines and application instructions.


Deadline: December 12, 2019